Josh Riggs - CEO and President, Director at Oncocyte Corp

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO and President, Director
Stock Symbol
OCX on Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
All Insider Reports
All Insider Reports

Josh Riggs - trading volume in the past year for Oncocyte Corp

Holdings reported by Josh Riggs for Oncocyte Corp

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock, no par value 3.51K $10.3K $2.95 Apr 11, 2024 Direct
Option to Purchase Common Stock 90K May 20, 2024 Direct Common Stock

Transactions reported by Josh Riggs for Oncocyte Corp

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.